European UPC IP Litigation
1,878 annotated decisions
Page 9 of 79 · 1,878 total
Irdeto B.V. v.DJI Europe B.V.. et.al.
In this legal proceeding before Mannheim (DE) Local Division (decision issued on 2026-06-12) under reference UPC_3F6FC747A3, Irdeto B.V. appeared in dispute with DJI Europe B.V.. et.al. concerning patent rights and legal remedies.
Insulet Corporation v.EOFLOW Co., Ltd.
This is a cost decision by the UPC Central Division (Milan) in which INSULET Corporation sought recovery of legal costs from EOFLOW Co. Ltd relating to EOFLOW's application for leave to appeal (UPC_CFI_1167/2025), the appellate proceedings concerning EOFLOW's appeal against a penalty order (UPC_CoA_930/2025), and ancillary remedies. The court found the application admissible and partially well-founded, determining that the objective interest corresponded to the EUR 150,000 penalty at stake, with
GlaxoSmithKline Biologicals SA v.Moderna Netherlands B.V. et. al
This is a Rule 105.5 procedural order issued by the judge-rapporteur following an interim conference in a patent infringement action and counterclaim for revocation. The claimant, GlaxoSmithKline Biologicals SA, asserts European Patent EP2590626 B1 against fifteen Moderna entities across multiple European jurisdictions. The interim conference was held online on 11 June 2026 to streamline and prepare the proceedings for the upcoming oral hearing, addressing topics suggested by both the Court and the parties.
Advanced Standard Communication LLC v.XIAOMI Inc. a.o.
In this legal proceeding before Munich (DE) Local Division (decision issued on 2026-06-11) under reference UPC_0805AED25C, Advanced Standard Communication LLC appeared in dispute with XIAOMI Inc. a.o. concerning patent rights and legal remedies.
Nixu FL IP Protection LLC v.Infoblox Inc. o. a.
This procedural order concerns a request by the Defendants (Infoblox Inc., Infoblox Germany GmbH, and Nomios Germany GmbH) for an order requiring the Claimant (Nixu FL IP Protection LLC) to provide security for legal costs under R. 158 RoP in patent infringement proceedings concerning EP 2 005 696 B1. The Defendants argued that the Claimant was a newly established litigation vehicle incorporated in Texas in March 2025, that it had no meaningful assets, and that enforcement of a cost award in Florida would be costly and uncertain. The Court addressed whether Florida's statutory requirements for recognizing foreign judgments justified ordering security, and whether the Claimant's asset structure warranted such an order.
Hologic, Inc. v.Siemens Healthineers AG a. o.
The appellants (Siemens entities) sought to withdraw their application for suspensive effect in appeal proceedings (UPC-CoA-94/2026) relating to a counterclaim for revocation, arguing the application had been filed accidentally. The Court of Appeal permitted the withdrawal under R. 265 RoP and granted the appellants' auxiliary request for reimbursement of 50% of the court fees (EUR 1,300), rejecting their main request for full reimbursement.
Speed Care Mineral GmbH v.Teleflex Life Sciences II LLC
This case concerns a request for discretionary review filed by Speed Care Mineral GmbH before the Court of Appeal of the Unified Patent Court, challenging the Local Division Hamburg's determination of the value in dispute for a Counterclaim for revocation at EUR 1,000,000. The Applicant argued that the value should have been set higher, at EUR 1,500,000, in accordance with the Administrative Committee's Guidelines. The Court of Appeal held the request admissible but dismissed it on the merits, finding that the Local Division had properly exercised its discretion given the short remaining duration of the patent and the size of the Applicant's company.
SharkNinja Operating LLC v.Groupe SEB France, S.A.S. SEB, SEB International Service (SIS) and Groupe SEB WMF Consumer GmbH
This case arose from SharkNinja's appeal of a Paris Local Division decision dismissing its application for provisional measures against SEB concerning EP 3 689 198. SharkNinja filed a request under R. 262A RoP to protect certain commercial market data as confidential, while SEB raised procedural objections regarding unsigned filings and requested extensions of time. The Court of Appeal addressed issues of electronic signature requirements under R. 4.1 RoP, retroactive extension of time periods under R. 9.3(a) RoP, and the scope of confidentiality protection, ultimately granting partial confidentiality protection with access limited to four named SEB employees.
FERRING B.V. et al v.ACCORD HEALTHCARE B.V. et al.
This is a procedural order from the Unified Patent Court (Local Division The Hague) concerning patent EP4512389 owned by Ferring B.V. The order addresses requests by defendants to align procedural deadlines for lodging preliminary objections and statements of defence. The judge-rapporteur granted the alignment request, setting uniform deadlines for all defendants while reserving rights regarding defendant 6's service conditions.
Nokia Technologies Oy a.o. v.Zhejiang Geely Holding Group Co., Ltd. a.o.
Nokia Technologies Oy and Nokia Solutions and Networks Oy had sought an ex parte 'Anti-Anti Suit Injunction' against Zhejiang Geely Holding Group and Hangzhou Geely New Energy Vehicle Sales before the Local Chamber Mannheim, which was granted on 20 April 2026 subject to a €600,000 security deposit. The applicants deposited the security on 21 April 2026. On 27 May 2026, with the respondents' consent, the applicants requested withdrawal of the application and release of the security. The Mannheim Local Chamber allowed the withdrawal, terminated the proceedings, and ordered the full release of the €600,000 security deposit.
Sanofi Biotechnologies SAS v.Amgen Inc. a. o.
In this legal proceeding before Düsseldorf (DE) Local Division (decision issued on 2026-06-08) under reference UPC_0C3E23552C, Sanofi Biotechnologies SAS appeared in dispute with Amgen Inc. a. o. concerning patent rights and legal remedies.
Morello Forni Italia srl e Morello Forni Sas di Morello Marco & C v.Gastroteam Abbe AB e Marciuliano Attrezzature di Salvatore Marciuliano
This is a cost decision by the Unified Patent Court, Local Division Milan, following a prior judgment (UPC CFI n. 802/2024) finding that Gastroteam Abbe AB and Salvatore Marciuliano infringed patent EP3691454. The claimants sought reimbursement of €62,719.20 in litigation costs. The court determined that the cost application was timely filed and properly notified to both defendants, and awarded a total of €62,359.32, reducing the representatives' fees from €45,359.88 to €45,000 based on the proportionality principle and the limited complexity of the case.
Nixu FL IP Protection LLC v.INFOBLOX INC. o.a.
The Claimant filed a patent infringement action against three Defendants concerning claim 2 of EP 2 005 696 B1, alleging infringement in Germany, France, Finland, and the United Kingdom. While jurisdiction over the two German-domiciled Defendants under Article 31 UPCA in conjunction with Article 4(1) Brussels-Ia-Regulation was not contested, the US-domiciled Defendant filed a Preliminary Objection challenging the Court's international jurisdiction. The core dispute centers on whether the UPC can assert jurisdiction over the US Defendant via the anchor defendant theory under Article 8(1) Brussels-Ia-Regulation, particularly with respect to the UK portion of the European Patent, given that the UK is not a UPCA member state.
Establishment Labs S.A. v.GC Aesthetics ParentCo Limited Nagor Limited GC Aesthetics Management Limited GC Aesthetics (Distribution) Limited GC Aesthetics (France) SAS EuroSilicone SAS GC Aesthetics Italy S.R.L. GC Aesthetics GmbH GC Aesthetics Spai
Establishment Labs S.A. (LABS), the proprietor of EP 3 107 487 B1, applied under Rule 263.3 RoP to limit its infringement action by withdrawing the UK designation portion of its claim against several GC Aesthetics defendants. The defendants sought dismissal, declarations of manifest inadmissibility under Rule 361 RoP, immediate cost awards, and prospective restrictions on future UPC claims. The Brussels Local Division granted LABS unconditional leave to limit its claims, held that Defendants 2 and 10 no longer had a legal basis to remain in the infringement proceedings but should stay for cost purposes, granted the defendants leave to limit their counterclaim, and granted leave to appeal.
KEEEX SAS v.Respondent
This is a procedural order from the UPC Local Division Paris concerning a request for revision (R. 333 RoP) filed by KEEEX SAS against an earlier order of June 25, 2026. The panel rejected all revision requests from both KEEEX and ADOBE, confirming the earlier order that had rejected KEEEX's request for further patent amendment under R. 30.2 RoP, declared the addition of new Truepic products as an inadmissible change of claim, and excluded certain late-filed elements from sections V and VI of KE
Align Technology, Inc. v.Angelalign Technology Inc., Angelalign France Technology SASU, Europe Angelalign Technology B.V., Angelalign Technology (Germany) GmbH and Italy Angelalign Technology S.R.L.
This procedural order concerns an application by Align Technology, Inc. under Rule 9.2 of the Rules of Proceedings to disregard late-filed non-infringement arguments raised by the Angelalign defendants in their rejoinder. Align argued that the defendants introduced new non-infringement arguments regarding features 1.3 and 1.3.4 of Claim 1 for the first time in their rejoinder, contrary to the front-loaded nature of the proceedings. The defendants requested dismissal of Align's requests and an opportunity to reply in writing to the disputed paragraphs and exhibits.
Establishment Labs S.A. v.GC Aesthetics ParentCo Limited Nagor Limited GC Aesthetics Management Limited GC Aesthetics (Distribution) Limited GC Aesthetics (France) SAS EuroSilicone SAS GC Aesthetics Italy S.R.L. GC Aesthetics GmbH GC Aesthetics Spai
Establishment Labs S.A. (LABS), the proprietor of EP 3 107 487 B1, applied under Rule 263.3 RoP to limit its infringement action by withdrawing the UK designation portion of its claim against several GC Aesthetics defendants. The defendants sought dismissal, declarations of manifest inadmissibility under Rule 361 RoP, immediate cost awards, and prospective restrictions on future UPC claims. The Brussels Local Division granted LABS unconditional leave to limit its claims, held that Defendants 2 and 10 no longer had a legal basis to remain in the infringement proceedings but should stay for cost purposes, granted the defendants leave to limit their counterclaim, and granted leave to appeal.
Dyson Technology Limited v.DREAME INTERNATIONAL (HONGKONG) LIMITED
Dyson Technology Limited filed a request to impose a penalty payment against Dreame International (Hongkong) Limited for alleged infringement of prior court decisions concerning European Patent EP3119235. During an oral hearing in a related case, the parties reached a settlement that included the withdrawal of the penalty request and an agreement that no cost reimbursement would be sought. The court permitted the withdrawal, confirmed that no cost decision was required, and set the value of the enforcement proceedings at EUR 100,000.
Gilead Sciences, Inc.,, 94404, USA v.Academy of Military Medical Sciences,, LANGUAGE OF PROCEEDINGS: English
This is a cost decision of the Unified Patent Court (Milan Central Division) following revocation proceedings (UPC_CFI_552/25) in which Gilead Sciences was the successful party. Gilead sought EUR 800,000 in recoverable legal costs from AMMS, which did not dispute the amount but requested a stay of payment pending appeal or alternatively payment by instalments. The court rejected both requests, holding that the automatic suspensive effect of Article 74(2) UPCA applies only to appeals on revocatio
Sun Patent Trust v.LYNK & CO International AB o. a.
Sun Patent Trust filed an infringement action against multiple defendants including Lynk & Co, Zeekr, Lotus Cars, and Smart Europe entities concerning EP 2 618 514. The Claimant requested permission to withdraw the infringement action, with all parties agreeing that each would bear its own costs. The Local Division Hamburg permitted the withdrawal and ordered reimbursement of 50% of the court fees to the Claimant.
Koninklijke KPN N.V. v.Oppo
In this legal proceeding before The Hague (NL) Local Division (decision issued on 2026-06-02) under reference UPC_65DAC4432F, Koninklijke KPN N.V. appeared in dispute with Oppo concerning patent rights and legal remedies.
Kodak Holding GmbH, Kodak GmbH, Kodak Graphic Communications GmbH v.Fujifilm Corporation
This decision of the Court of Appeal of the Unified Patent Court, issued on 2 June 2026, addresses multiple legal questions arising from proceedings concerning European Patent EP 3 511 174 validated in Germany and the United Kingdom. The headnotes cover issues of claim construction (particularly regarding numerical values and manufacturing tolerances), private prior use under Article 28 UPCA and German law, front-loaded proceedings under Rule 29(c) RoP, international jurisdiction under Article 34 UPCA and Brussels I bis, and the exercise of international jurisdiction including the application of comity principles when patents validated outside the UPC territory are at issue.
La Siddhi Consultancy Limited. v.Athena Pharmaceutiques SAS, Substipharm
This is a revocation action concerning European Patent No. 3 592 333 before the Court of First Instance of the Unified Patent Court (Central Division, Milan Seat). The claimant filed an application under Rule 262A RoP seeking to restrict access to the unredacted version of Exhibit MW21, a non-public agreement with a third party, to an 'attorneys' eyes only' confidentiality regime. The defendants sought broader access, including for their Head of Legal, Indian external legal advisers, and external experts. The Court granted a confidentiality regime but allowed access to the defendants' external representatives and two named natural persons, rejecting the requests for Indian counsel and external experts.
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. v.HMD Global Oy
This procedural order summarizes the interim conference held in two related patent infringement actions (UPC_CFI_494/2025 and UPC_CFI_495/2025) brought by Fraunhofer-Gesellschaft against HMD Global Oy concerning European patents EP 2 380 167 and EP 2 609 590. The judge-rapporteur recorded the parties' agreement on the value of the proceedings, proposed a framework for reimbursable legal costs, and outlined the schedule and structure of the upcoming oral hearing. Key legal issues were identified for each case, covering claim construction, validity, priority, and infringement questions relating to audio coding/upmixing technology.